Foresite Capital
Foresite Capital is a multi-stage investment firm specializing in healthcare and life sciences, managing $2 billion in assets. Established in 2011, the firm focuses on growth equity investments across various sectors, including pharmaceuticals, biotechnology, and healthcare technology. Foresite Capital employs a data-driven and scientific approach to its investment analysis, collaborating closely with portfolio companies through a multidisciplinary team of professionals, including scientists, engineers, analysts, and clinicians. This collaborative strategy aims to address significant unmet clinical needs by supporting promising businesses at different stages of their development. The firm places particular emphasis on companies that leverage data science and machine intelligence within the healthcare sector. Foresite Capital is headquartered in San Francisco, with an additional office in New York.
Juvenescence Limited is a British Virgin Islands-based holding company focused on investing in human aging and longevity. The company has raised substantial capital to establish a comprehensive ecosystem aimed at addressing aging, age-related diseases, and regeneration. Juvenescence aims to leverage recent scientific advancements to develop therapeutics that can significantly extend human healthspan and lifespan. The company's approach involves creating and partnering with new ventures that specialize in longevity-related therapies, in-licensing promising compounds from academic and industry sources, and collaborating with leading scientists and research institutions. Their work is grounded in a modern understanding of the biological mechanisms of aging, allowing them to create evidence-based treatments for age-associated diseases. Ultimately, Juvenescence seeks to enhance both lifespan and healthspan by developing therapies that slow the aging process and promote rejuvenation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.